Bromodeoxyuridine vs Mycophenolic
Mechanistic comparison of Bromodeoxyuridine and Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
9
Shared Targets
25%
Jaccard Similarity
20%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
Bromodeoxyuridine and Mycophenolic share 9 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.250 means 25% of the combined target set is bound by both compounds. The IDF-weighted score of 0.203 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.